Wird geladen...
Harnessing the immune response to target tumors
Development of “immune-based targeted therapy” in oncology has limited experience with signal pathway modulation. However, as we have become better versed in understanding immune function related to anticancer response, “hints” of specific targets associated with sensitivity and resistance have been...
Gespeichert in:
| Veröffentlicht in: | F1000Res |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
F1000Research
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5461900/ https://ncbi.nlm.nih.gov/pubmed/28620466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.10795.1 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|